Theravance Biopharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
TBPH Nasdaq 2830 www.theravance.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Theravance Biopharma, Inc.

Sector Update: Healthcare Stocks Higher Late Afternoon - Jun 29th, 2026 1:59 pm
Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders - Jun 29th, 2026 6:44 am
Zymeworks to Buy Theravance for Lung Disease Drug. Both Stocks Are Sliding. - Jun 29th, 2026 6:39 am
Zymeworks to Acquire Theravance Biopharma in $929 Million Deal - Jun 29th, 2026 4:19 am
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT - Jun 29th, 2026 4:00 am
Zymeworks to Acquire Theravance Biopharma, Inc. - Jun 29th, 2026 4:00 am
Theravance, after clinical setbacks, agrees to $929M buyout - Jun 29th, 2026 2:42 am
Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains? - Jun 25th, 2026 5:48 am
Are Options Traders Betting on a Big Move in Theravance Biopharma Stock? - May 13th, 2026 7:27 am
TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle - May 8th, 2026 11:26 am
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 7th, 2026 6:30 am
Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates - May 6th, 2026 3:10 pm
CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised - May 1st, 2026 9:15 am
Laughing Water Capital’s New Position: Theravance Biopharma (TBPH) - Apr 24th, 2026 8:27 am
B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 - Apr 19th, 2026 6:09 pm
Theravance Stock Declines Around 17% in Three Months: Here's Why - Apr 16th, 2026 11:13 am
Zacks Industry Outlook Highlights Indivior Pharmaceuticals, Catalyst Pharmaceuticals, Theravance Biopharma, Relmada Therapeutics and Avalo Therapeutics - Apr 6th, 2026 9:10 am
5 Small Drug Stocks to Buy as Sector Recovery Gains Strength - Apr 2nd, 2026 8:00 am
Theravance's Q4 Earnings and Revenues Miss Estimates - Mar 20th, 2026 12:45 pm
All You Need to Know About Theravance Bio (TBPH) Rating Upgrade to Strong Buy - Mar 20th, 2026 10:00 am